Page results
-
UCLH is supporting a new UK-wide health and care research registry, as part of the nation’s biggest-ever recruitment drive to clinical trials.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
Information for patients having a robotic-assisted thoracic surgery (RATS).
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
This page provides information on transperineal biopsies of the prostate.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
File results
-
FOI/2023/0879 - Incidence and treatment of colorectal cancer
-
FOI/2023/0880 - Digital tools to support patient management for Musculoskeletal (MSK)/ women’s pelvic health
-
FOI/2023/0884 - Cases treated from hyaluronic acid dermal fillers
-
FOI/2023/0885 - Treatment of patients on wards
-
FOI/2023/0886 - Charges to overseas visitors regulations
-
FOI/2023/0891 - Organisational structure for team managers and service managers
-
FOI/2023/0892 - Decontamination services/ AER machines
-
FOI/2023/0893 - Staff responsible for facilities, estates, property and finance
-
FOI/2023/0895 - Midlines/ peripherally inserted central catheters PICCs
-
FOI/2023/0897 - Supplier contracted by Trust for business rates mitigation appeals